Stimu Hair
Natural health product licensed in Canada
- Licence holder
- 2158894 Ontario Inc.
- NPN or DIN-HM
- 80028532
- Status
- Active licence
- Licence date
- 7 December 2011
- Revision date
- 24 September 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycine max Source : Fève Potency : 10.61 mg ÉAI Aglycone isoflavone equivalents | 47.5 mg | Not calculated |
| Equisetum arvense Source : Parties aériennes Extraction ratio : 6:1 Dry plant equivalent : 855 mg Potency : 7 % Silica | 142.5 mg | Not calculated |
| Capsicum annuum Source : Fruit Potency : 2.5 % capsaicin | 60 mg | Not calculated |
| Capsicum annuum Source : Fruit Potency : 1.5 mg | Not specified | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | Not specified | 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May help to promote hair growth in people suffering hair loss associated with androgenic alopecia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80028532
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging